Loading...
High Valuation Will Constrain Recovery Amid Regulatory And Cost Pressures
AnalystLowTarget's Fair Value
US$3.00
32.3% overvalued intrinsic discount04 Sep
US$3.97
1Y
-60.8%7D
-0.5%1Y
-60.8%7D
-0.5%You can edit this narrative until Aug 23 10:15 PM. Then, changes will post as Updates.